Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.

October 3, 2023

Excited to share that Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm, contributing to the evolution of Sweden’s medical industry.

Thanks to EU Startup News for the acknowledgement!

” This startup is working diligently to enhance treatment decisions and outcomes in cancer care. Their work exemplifies the transformative impact of technological adoption in health care.”

MORE NEWS:

Professor Daniel Hayes Joins Stratipath’s Scientific Advisory Board

Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year

Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital

Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.

MORE NEWS:

Professor Daniel Hayes Joins Stratipath’s Scientific Advisory Board

Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year

Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital

Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)

Press releases:

Professor Daniel Hayes Joins Stratipath’s Scientific Advisory Board

Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital

Stratipath and Roche Join Forces to Help Expand Access to AI-Powered Precision Diagnostics

A new validation study on the prognostic performance of Stratipath Breast.

IN THE MEDIA:

Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year

Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)

Podcast: “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”

Article at Genomeweb: ”Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Test”